Journal articles on the topic 'Piperazines; Pharmacology'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Piperazines; Pharmacology.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Šilhánková, Alexandra, Karel Šindelář, Karel Dobrovský, Ivan Krejčí, Jarmila Hodková, and Zdeněk Polívka. "Synthesis of New L-Proline Amides with Anticonvulsive Effect." Collection of Czechoslovak Chemical Communications 61, no. 7 (1996): 1085–92. http://dx.doi.org/10.1135/cccc19961085.
Full textElliott, Simon. "Current awareness of piperazines: pharmacology and toxicology." Drug Testing and Analysis 3, no. 7-8 (2011): 430–38. http://dx.doi.org/10.1002/dta.307.
Full textDolan, Sean B., Ritu A. Shetty, Michael J. Forster, and Michael B. Gatch. "Impure but not inactive: Behavioral pharmacology of dibenzylpiperazine, a common by-product of benzylpiperazine synthesis." Journal of Psychopharmacology 32, no. 7 (2018): 802–10. http://dx.doi.org/10.1177/0269881118780613.
Full textVeselkina, O. S., I. L. Solovtsova, N. N. Petrishchev, et al. "Influence of N,N′-Substituted Piperazines on Cytolysis." Pharmaceutical Chemistry Journal 49, no. 11 (2016): 743–48. http://dx.doi.org/10.1007/s11094-016-1363-8.
Full textPopugaeva, Elena, Daria Chernyuk, Hua Zhang, et al. "Derivatives of Piperazines as Potential Therapeutic Agents for Alzheimer’s Disease." Molecular Pharmacology 95, no. 4 (2019): 337–48. http://dx.doi.org/10.1124/mol.118.114348.
Full textKlochkova, I. N., N. N. Semenova, A. A. Safonova, and M. V. Noritsina. "Search for potential cholinesterase inhibitors among substituted pyrrolidines and piperazines." Pharmaceutical Chemistry Journal 33, no. 12 (1999): 638–41. http://dx.doi.org/10.1007/bf02974938.
Full textWeigl, Manuela, та Bernhard Wünsch. "Synthesis of bridged piperazines with σ receptor affinity". European Journal of Medicinal Chemistry 42, № 10 (2007): 1247–62. http://dx.doi.org/10.1016/j.ejmech.2007.02.005.
Full textKersten, Brian P., and Megan E. McLaughlin. "Toxicology and Management of Novel Psychoactive Drugs." Journal of Pharmacy Practice 28, no. 1 (2014): 50–65. http://dx.doi.org/10.1177/0897190014544814.
Full textPatel, Divyesh, Rahul Patel, Premlata Kumari, and Navin Patel. "In vitro antimicrobial assessment of coumarin-based s-triazinyl piperazines." Medicinal Chemistry Research 21, no. 8 (2011): 1611–24. http://dx.doi.org/10.1007/s00044-011-9676-3.
Full textYurttaş, Leyla, Zafer Asım Kaplancıklı, and Yusuf Özkay. "Design, synthesis and evaluation of new thiazole-piperazines as acetylcholinesterase inhibitors." Journal of Enzyme Inhibition and Medicinal Chemistry 28, no. 5 (2012): 1040–47. http://dx.doi.org/10.3109/14756366.2012.709242.
Full textvan der Zee, P., and W. Hespe. "Interaction between substituted 1-[2-(diphenylmethoxy)ethyl] piperazines and dopamine receptors." Neuropharmacology 24, no. 12 (1985): 1171–74. http://dx.doi.org/10.1016/0028-3908(85)90150-9.
Full textSoboleva, S. G., A. F. Galatin, T. L. Karaseva, A. V. Golturenko, and S. A. Andronati. "Synthesis and Pharmacological Properties of 1-Aryl-4-(3′4′,5′-trimethoxybenzoyl)piperazines." Pharmaceutical Chemistry Journal 39, no. 5 (2005): 236–38. http://dx.doi.org/10.1007/s11094-005-0124-x.
Full textMokrov, G. V., A. M. Likhosherstov, V. V. Barchukov, et al. "Synthesis and Cardiotropic Activity of 1-(Methoxybenzyl)-4-{2-[(Methoxybenzyl)-Amino]Ethyl}Piperazines." Pharmaceutical Chemistry Journal 53, no. 9 (2019): 786–91. http://dx.doi.org/10.1007/s11094-019-02080-2.
Full textCaccia, S., I. Conti, A. Notarnicola, and R. Urso. "Lipophilicity and disposition of 1-aryl-piperazines in the rat." Xenobiotica 17, no. 5 (1987): 605–16. http://dx.doi.org/10.3109/00498258709043967.
Full textSlater, Lewis M., Gabriel F. Eilon, Jirong Gu, John W. Jacobs, and Kaoru Hara. "Tumor apoptosis induced by epoxide-containing piperazines, a new class of anti-cancer agents." Cancer Chemotherapy and Pharmacology 45, no. 3 (2000): 183–91. http://dx.doi.org/10.1007/s002800050028.
Full textSilvio Caccia. "N-Dealkylation of Arylpiperazine Derivatives: Disposition and Metabolism of the 1-Aryl-Piperazines Formed." Current Drug Metabolism 8, no. 6 (2007): 612–22. http://dx.doi.org/10.2174/138920007781368908.
Full textYAROSH, H., E. KATZ, A. COOP, and W. FANTEGROSSI. "MDMA-like behavioral effects of N-substituted piperazines in the mouse." Pharmacology Biochemistry and Behavior 88, no. 1 (2007): 18–27. http://dx.doi.org/10.1016/j.pbb.2007.06.007.
Full textValluri, Kishore K., Tejeswara R. Allaka, IV Kasi Viswanath, and Nagaraju PVVS. "Synthesis and Antibacterial / Anticancer Activities of Compounds Containing Pyrazole Ring Linked to Piperazines." Current Bioactive Compounds 16, no. 4 (2020): 419–31. http://dx.doi.org/10.2174/1573407215666190111124513.
Full textAngeli, Andrea, Niccolò Chiaramonte, Dina Manetti, Maria Novella Romanelli, and Claudiu T. Supuran. "Investigation of piperazines as human carbonic anhydrase I, II, IV and VII activators." Journal of Enzyme Inhibition and Medicinal Chemistry 33, no. 1 (2017): 303–8. http://dx.doi.org/10.1080/14756366.2017.1417277.
Full textHuang, Rong, Yao Sheng, Ding Wei, Jianghui Yu, Hongli Chen, and Biao Jiang. "Bis(vinylsulfonyl)piperazines as efficient linkers for highly homogeneous antibody-drug conjugates." European Journal of Medicinal Chemistry 190 (March 2020): 112080. http://dx.doi.org/10.1016/j.ejmech.2020.112080.
Full textGupta, Sonal, Deepti Pandey, Dhanaraju Mandalapu, et al. "Novel aryl piperazines for alleviation of ‘andropause’ associated prostatic disorders and depression." European Journal of Medicinal Chemistry 132 (May 2017): 204–18. http://dx.doi.org/10.1016/j.ejmech.2017.03.036.
Full textNguyen, William, Madeline G. Dans, Anna Ngo, et al. "Structure activity refinement of phenylsulfonyl piperazines as antimalarials that block erythrocytic invasion." European Journal of Medicinal Chemistry 214 (March 2021): 113253. http://dx.doi.org/10.1016/j.ejmech.2021.113253.
Full textRudner-Varga, Vanda, Philip K. Ahring, Dinesh Indurthi та ін. "Exploring the structure activity relationships of halogen containing N-(pyridin-3-yl)-piperazines and homopiperazines at α4β2 nAChRs". Biochemical Pharmacology 97, № 4 (2015): 623. http://dx.doi.org/10.1016/j.bcp.2015.08.010.
Full textSchifano, Fabrizio. "Novel psychoactive substances (NPS): clinical and pharmacological issues." Drugs and Alcohol Today 15, no. 1 (2015): 21–27. http://dx.doi.org/10.1108/dat-10-2014-0035.
Full textGenaro-Mattos, Thiago C., Keri A. Tallman, Luke B. Allen, et al. "Dichlorophenyl piperazines, including a recently-approved atypical antipsychotic, are potent inhibitors of DHCR7, the last enzyme in cholesterol biosynthesis." Toxicology and Applied Pharmacology 349 (June 2018): 21–28. http://dx.doi.org/10.1016/j.taap.2018.04.029.
Full textNeganova, Margarita E., Sergey G. Klochkov, Sergey A. Pukhov, et al. "Synthesis and Cytotoxic Activity of Azine Derivatives of 6-Hydroxyxanthanodiene." Current Cancer Drug Targets 20, no. 9 (2020): 666–74. http://dx.doi.org/10.2174/1568009620999200421200338.
Full textPurohit, Deepika, Vandana Saini, Sanjiv Kumar, Ajit Kumar та Balasubramanian Narasimhan. "Three-dimensional Quantitative Structure-activity Relationship (3DQSAR) and Molecular Docking Study of 2-((pyridin-3-yloxy)methyl) Piperazines as α7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders". Mini-Reviews in Medicinal Chemistry 20, № 11 (2020): 1031–41. http://dx.doi.org/10.2174/1389557519666190904151227.
Full textCHEN, JIANHONG, AGRIPINA G. DEACIUC, LINDA P. DWOSKIN, PETER A. CROOKS та DONGLU BAI. "N, N –Disubstituted piperazines and homopiperazines: Synthesis and affinities at α4β2* and α7* neuronal nicotinic acetylcholine receptors". Journal of Enzyme Inhibition and Medicinal Chemistry 21, № 6 (2006): 667–80. http://dx.doi.org/10.1080/14756360600900513.
Full textKortagere, Sandhya, Peter Gmeiner, Harel Weinstein, and John A. Schetz. "Certain 1,4-Disubstituted Aromatic Piperidines and Piperazines with Extreme Selectivity for the Dopamine D4 Receptor Interact with a Common Receptor Microdomain." Molecular Pharmacology 66, no. 6 (2004): 1491–99. http://dx.doi.org/10.1124/mol.104.001321.
Full textAl-Soud, Yaseen, Najim Al-Masoudi, Hamed Hassan, Erik De Clercq, and Christophe Pannecouque. "Nitroimidazoles. V. Synthesis and anti-HIV evaluation of new 5-substituted piperazinyl-4-nitroimidazole derivatives." Acta Pharmaceutica 57, no. 4 (2007): 379–93. http://dx.doi.org/10.2478/v10007-007-0031-7.
Full textGaur, Stuti, Philip Prathipati, Mridula Saxena, and Anil K. Saxena. "CoMFA AND CoMSIA STUDIES ON A SET OF BENZYL PIPERAZINES, PIPERADINES, PYRAZINOPYRIDOINDOLES, PYRAZINOISOQUINOLINES AND SEMI RIGID ANALOGS OF DIPHENHYDRAMINE." Medicinal Chemistry Research 13, no. 8-9 (2004): 746–57. http://dx.doi.org/10.1007/s00044-004-0114-7.
Full textXu, Hui. "Progress of Bis(heteroaryl)piperazines (BHAPs) as Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) against Human Immunodeficiency Virus Type 1 (HIV-1)." Mini-Reviews in Medicinal Chemistry 10, no. 1 (2010): 62–72. http://dx.doi.org/10.2174/138955710791112578.
Full textMizuki, Y., I. Fujiwara, T. Yamaguchi, and Y. Sekine. "Structure-related inhibitory effect of antimicrobial enoxacin and derivatives on theophylline metabolism by rat liver microsomes." Antimicrobial Agents and Chemotherapy 40, no. 8 (1996): 1875–80. http://dx.doi.org/10.1128/aac.40.8.1875.
Full textPatel, Rahul V., Amit B. Patel, Premlata Kumari, and Kishor H. Chikhalia. "Synthesis of novel 3-(5-sulfanyl-1,3,4-oxadiazol-2-yl)-2H-chromen-2-one condensed s-triazinyl piperazines and piperidines as antimicrobial agents." Medicinal Chemistry Research 21, no. 10 (2011): 3119–32. http://dx.doi.org/10.1007/s00044-011-9842-7.
Full textMohamed, Osama G., Angela A. Salim, Zeinab G. Khalil, Ahmed H. Elbanna, Paul V. Bernhardt, and Robert J. Capon. "Chrysosporazines F–M: P-Glycoprotein Inhibitory Phenylpropanoid Piperazines from an Australian Marine Fish Derived Fungus, Chrysosporium sp. CMB-F294." Journal of Natural Products 83, no. 2 (2020): 497–504. http://dx.doi.org/10.1021/acs.jnatprod.9b01181.
Full textElbanna, Ahmed H., Amila Agampodi Dewa, Zeinab G. Khalil, and Robert J. Capon. "Precursor-Directed Biosynthesis Mediated Amplification of Minor Aza Phenylpropanoid Piperazines in an Australian Marine Fish-Gut-Derived Fungus, Chrysosporium sp. CMB-F214." Marine Drugs 19, no. 9 (2021): 478. http://dx.doi.org/10.3390/md19090478.
Full textDevine, R., M. Kelada, S. Leonard, et al. "Design, synthesis, and biological evaluation of aryl piperazines with potential as antidiabetic agents via the stimulation of glucose uptake and inhibition of NADH:ubiquinone oxidoreductase." European Journal of Medicinal Chemistry 202 (September 2020): 112416. http://dx.doi.org/10.1016/j.ejmech.2020.112416.
Full textJadala, Chetna, Manda Sathish, Pratibha Anchi, et al. "Synthesis of Combretastatin‐A4 Carboxamidest that Mimic Sulfonyl Piperazines by a Molecular Hybridization Approach: in vitro Cytotoxicity Evaluation and Inhibition of Tubulin Polymerization." ChemMedChem 14, no. 24 (2019): 2052–60. http://dx.doi.org/10.1002/cmdc.201900541.
Full textBindu, B., S. Vijayalakshmi, and A. Manikandan. "Synthesis and discovery of triazolo-pyridazine-6-yl-substituted piperazines as effective anti-diabetic drugs; evaluated over dipeptidyl peptidase-4 inhibition mechanism and insulinotropic activities." European Journal of Medicinal Chemistry 187 (February 2020): 111912. http://dx.doi.org/10.1016/j.ejmech.2019.111912.
Full textWenceslau, João P. S., Dávila F. de Souza, Maria C. F. de Oliveira, et al. "Novel Lapachol Derivatives and Their Antioxidant Activity." Natural Product Communications 1, no. 8 (2006): 1934578X0600100. http://dx.doi.org/10.1177/1934578x0600100812.
Full textValenta, Vladimír, Zdeněk Prošek, Jiřina Metyšová, Martin Valchář, Antonín Dlabač, and Miroslav Protiva. "Cataleptic and noncataleptic neuroleptic agents: Synthesis and pharmacology of 4-(2-chloro and 8-chloro substituted 10,11-dihydrodibenzo[b,f]thiepin-10-yl)piperazine-1-ylalkyl ethers and sulfides." Collection of Czechoslovak Chemical Communications 50, no. 5 (1985): 1070–77. http://dx.doi.org/10.1135/cccc19851070.
Full textLaïos, Ioanna, Anny Cleeren, Guy Leclercq, et al. "Effects of (R,S)/(S,R)-4,5-bis(2-chloro-4-hydroxyphenyl)-2-imidazolines and (R,S)/(S,R)-2,3-bis(2-chloro-4-hydroxyphenyl)piperazines on estrogen receptor alpha level and transcriptional activity in MCF-7 cells." Biochemical Pharmacology 74, no. 7 (2007): 1029–38. http://dx.doi.org/10.1016/j.bcp.2007.06.045.
Full textGhasi, Samuel, and Obiageli Odurukwe. "The Effects of Sub-chronic Piperazine Treatment on the Liver Status of a Rat Model." Pharmacologia 2, no. 9 (2011): 259–64. http://dx.doi.org/10.5567/pharmacologia.2011.259.264.
Full textAbate, Carmen, Mauro Niso, Marialessandra Contino та ін. "Inside Cover: 1-Cyclohexyl-4-(4-arylcyclohexyl)piperazines: Mixed σ and Human Δ8-Δ7 Sterol Isomerase Ligands with Antiproliferative and P-Glycoprotein Inhibitory Activity (ChemMedChem 1/2011)". ChemMedChem 6, № 1 (2010): 2. http://dx.doi.org/10.1002/cmdc.201090062.
Full textGhasi, S., O. Odurukwe, and S. Ufelle. "Appraisal of the Kidney Status of the Rat Model to Sub-acute Treatment with Piperazine Citrate." Pharmacologia 3, no. 8 (2012): 306–12. http://dx.doi.org/10.5567/pharmacologia.2012.306.312.
Full textSharma, Anjali, Sharad Wakode, Faizana Fayaz, Shaik Khasimbi, Faheem H. Pottoo, and Avneet Kaur. "An Overview of Piperazine Scaffold as Promising Nucleus for Different Therapeutic Targets." Current Pharmaceutical Design 26, no. 35 (2020): 4373–85. http://dx.doi.org/10.2174/1381612826666200417154810.
Full textMooney, R. D., M. Y. Shi, and R. W. Rhoades. "Modulation of retinotectal transmission by presynaptic 5-HT1B receptors in the superior colliculus of the adult hamster." Journal of Neurophysiology 72, no. 1 (1994): 3–13. http://dx.doi.org/10.1152/jn.1994.72.1.3.
Full textMartin, R. J., M. A. Valkanov, V. M. E. Dale, A. P. Robertson, and I. Murray. "Electrophysiology ofAscarismuscle and anti-nematodal drug action." Parasitology 113, S1 (1996): S137—S156. http://dx.doi.org/10.1017/s0031182000077945.
Full textSzczepanska, Katarzyna, Kamil Kuder, and Katarzyna Kiec-Kononowicz. "Histamine H3 Receptor Ligands in the Group of (Homo)piperazine Derivatives." Current Medicinal Chemistry 25, no. 14 (2018): 1609–26. http://dx.doi.org/10.2174/0929867325666171123203550.
Full textMorris, Julia E., Xiao-Su Pan, and L. Mark Fisher. "Grepafloxacin, a Dimethyl Derivative of Ciprofloxacin, Acts Preferentially through Gyrase in Streptococcus pneumoniae: Role of the C-5 Group in Target Specificity." Antimicrobial Agents and Chemotherapy 46, no. 2 (2002): 582–85. http://dx.doi.org/10.1128/aac.46.2.582-585.2002.
Full text